dc.contributor.author |
Topleninov E. |
|
dc.contributor.author |
Elshin L. |
|
dc.date.accessioned |
2018-04-05T07:09:22Z |
|
dc.date.available |
2018-04-05T07:09:22Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
0798-1015 |
|
dc.identifier.uri |
http://dspace.kpfu.ru/xmlui/handle/net/129687 |
|
dc.description.abstract |
© 2017. This article presents conceptual approaches to assessment and analysis of efficiency of the pharmaceutical industry development by the example of the Republic of Tatarstan based on the use of methods of normative scorecard. The results of the conducted research allow to identify the mechanisms and priority development fields for the sectors of the economy under study, on the basis of systematic analysis of the highlighted key series of indicators that describe various aspects of sectoral development: financial results of the industry development and capability to increase investment and innovation activity directly arising from them; structure of cost for the production, which determines the capabilities of output of competitiveproducts; financial stability and liquidity of the industry development, which provides capability of financial security of the long-term progressive development; and use of labor resources, their composition and structure. Key development fields of the pharmaceutical industry of the Republic of Tatarstan during the current and perspective periods of development have been formulated and defined in the work based on the results of assessment of competitiveness of the previously formed business processes that describe sectoral development. |
|
dc.relation.ispartofseries |
Espacios |
|
dc.subject |
Efficiency of development of pharmaceutical industry |
|
dc.subject |
Integral estimation of the efficiency of sectoral development |
|
dc.subject |
Normative scorecard |
|
dc.subject |
Priority fields of formation of an industrial cluster |
|
dc.subject |
Reference sequence of indicators of sectoral development |
|
dc.title |
Methods for identifying the priority development fields of the regional pharmaceutical cluster based on the mechanisms of using the Balanced Scorecard |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
33 |
|
dc.relation.ispartofseries-volume |
38 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.source.id |
SCOPUS07981015-2017-38-33-SID85026775992 |
|